Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 72 Neoplasms 46 Squamous Cell Carcinoma of Head and Neck 45 Head and Neck Neoplasms 35 Lung Neoplasms 34 Uterine Cervical Neoplasms 27 Neoplasm Metastasis 25 Unspecified Adult Solid Tumor, Protocol Specific 24 Stomach Neoplasms 24 Ovarian Neoplasms 24 Small Cell Lung Carcinoma 20 Pancreatic Neoplasms 18 Colorectal Neoplasms 18 Carcinoma, Squamous Cell 17 Esophageal Neoplasms 16 Cholangiocarcinoma 16 Breast Neoplasms 15 Mesothelioma, Malignant 14 Melanoma 13 Urinary Bladder Neoplasms 12 Mesothelioma 11 Fallopian Tube Neoplasms 11 Carcinoma, Ovarian Epithelial 11 Sarcoma 9 Gallbladder Neoplasms 9 Esophageal Squamous Cell Carcinoma 9 Biliary Tract Neoplasms 9 Carcinoma 8 Recurrence 7 Peritoneal Neoplasms 7

Interventions

genexol-PM 1 gadobutrol 1 Population Groups 1 NK Cell Lectin-Like Receptor Subfamily B 1 Exercise 1 Drug Therapy 1 Counseling 1 Cisplatin 1 AGuIX 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Gynecologic Cancer × Cisplatin × Clear all

NCT03308604 2021-07-07

NANOCOL

Gustave Roussy, Cancer Campus, Grand Paris

Phase 1 Unknown

Gynecologic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡